Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease

Fig. 2

Mean change from baseline to End of Maintenance for coprimary efficacy variables (Full Analysis Set, last observation carried forward): (a) Apathy Scale as rated by the patient and (b) Unified Parkinson's Disease Rating Scale II + III total score. Abbreviations: ANCOVA: analysis of covariance; CI: confidence interval; LS: least squares; SD: standard deviation; SE, standard error

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us